Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Lupus Nephritis or a Mimic?

Matthew J. Mandell, DO, Yishui Chen, MD, Prerna Rastogi, MD, PhD, & Rebecca Tuetken, MD, PhD  |  Issue: November 2022  |  November 10, 2022

FIGURE 1: JONES METHENAMINE SILVER (40X)

Segmental spikes and holes noted in glomerular capillary loops.

[kevel_ad id = "native"]

(Click to enlarge.)

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Syphilis, an ancient disease caused by the spirochete Treponema pallidum, has been historically referred to as the great mimicker given its heterogenous presentation. Both systemic lupus erythematosus (SLE) and syphilis can have multi-systemic involve­ment. Both parvovirus B19 and syphilis have been reported to cause histologic features similar to those seen in lupus nephritis. 

We present a case in which co-infection with syphilis and parvovirus B19 could have been mistaken for lupus nephritis. We highlight clinical features to help differentiate between lupus nephritis and nephrotic syndrome caused by co-infection with syphilis and parvovirus B19. Making the correct diagnosis has important implications: Nephrotic syndrome associated with parvovirus B19 often improves spontaneously and that with syphilis improves with penicillin, whereas lupus nephritis requires systemic immunosuppression. 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Case Presentation

A 34-year-old Angolese man presented with lower extremity edema, headache, malaise, arthralgias, rash, diarrhea and chest pain of six weeks’ duration. He previously was evaluated at an urgent care clinic and was prescribed an oral non-steroidal anti-inflammatory drug for chest pain and myalgias, with sympto­matic improvement. Renal biopsy was con­cerning for classes II and V lupus nephritis, for which a rheuma­tologist was consulted. 

His creatinine was 1.4 mg/dL (ref­erence range [RR] 0.75–1.20 mg/dL for men) on admission. Liver function tests were normal, except for an isolated elevation in alkaline phosphatase con­firmed to be of hepatic etiology, with a corresponding elevation in gamma-glutamyl transferase. 

FIGURE 2: ELECTRON MICROSCOPY

Rare subepithelial and mesangial immune complex mediated type electron dense deposits present. Moderate podocyte epithelial foot process effacement is shown.

(Click to enlarge.)

The patient had recently been diag­nosed with syphilis and treated with intramuscular penicillin a few weeks prior to his admission. His medical history included a prior diagnosis of COVID-19 and a remote history of malaria. Neither he nor his family had any history of autoimmune disease. He had not been taking any regular medications prior to admission. He denied use of illicit substances and had no travel outside the U.S. in several years. He reported being sexually active with male partners. 

On admission to our hospital, his exam revealed prominent bilateral axillary and bilateral inguinal lymph nodes, soft tissue swelling in both ankles and pretibial pitting edema. Examination found no appreciable rashes on the skin, including a normal genital exam with no ulcerative lesions. The patient denied malar rash, photosensitivity, Raynaud’s phenomenon, history of venous thromboembolic events, dry mouth, dry eye, history of seizure or stroke, history of cytopenias, nasal or oral ulcers, or hair loss.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:case reportFellowsFellows ForumFellows-in-TrainingLupus nephritisparvovirus B19syphilis

Related Articles

    A Case of Lupus Podocytopathy

    June 17, 2024

    Kidney involvement is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). Collectively termed lupus nephritis, SLE with kidney involvement comes in many subtypes. The current classification by the International Society of Nephrology/Renal Pathology Society (ISN/RPS), however, does not include lupus podocytopathy, which, through various clinical and epidemiologic studies, has recently been…

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

    Tacrolimus Use for Lupus Nephritis Raises Debate over Role in North American Population

    October 10, 2016

    The following summary regarding use of tacrolimus (TAC) in lupus nephritis highlights a number of debatable points. Although the role of TAC in lupus nephritis remains unproved for North American populations, it might be an excellent option in some clinical situations. These situations include lupus flare during pregnancy and also for lupus nephritis when the…

    Immunosuppressive Treatment for Lupus in the Next Decade

    April 13, 2011

    It’s time for a new strategy

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences